NanoViricides Total Current Liabilities 2011-2026 | NNVC

Annual Total Current Liabilities NanoViricides

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.31 M	1.36 M	534 K	413 K	351 K	2.16 M	2.85 M	882 K	4.67 M	6.74 M	601 K	1.23 M	1.18 M	1.78 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.74 M	351 K	1.86 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
Amarin Corporation plc AMRN	194 M	$ 14.67	-	$ 6.09 B	Irlanda
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Cabaletta Bio CABA	50.2 M	$ 2.82	-	$ 283 M	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	66.3 M	-	-6.81 %	$ 3.04 B	USA
CollPlant Biotechnologies Ltd. CLGN	2.97 M	$ 0.66	-0.45 %	$ 7.56 M	Israel
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
CEL-SCI Corporation CVM	4.62 M	$ 3.47	-	$ 221 M	USA
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
Denali Therapeutics DNLI	102 M	$ 19.74	-	$ 3.25 B	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	60.7 M	$ 1.29	-	$ 329 M	Britain
Esperion Therapeutics ESPR	301 M	$ 2.85	-	$ 592 M	USA
EyePoint Pharmaceuticals EYPT	37 M	$ 13.06	-	$ 957 K	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	3.8 M	$ 1.09	-	$ 22.4 M	Israel
Enochian Biosciences ENOB	29.2 M	-	-	$ 40.5 M	USA
Equillium EQ	2.93 M	$ 2.06	-	$ 118 M	USA
Eton Pharmaceuticals ETON	38.5 M	$ 23.45	-	$ 631 M	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	149 M	$ 47.55	-	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	6.01 M	$ 4.45	-	$ 853 M	Canada